Britain's medicines regulator said on Friday it had extended approval of the COVID-19 vaccine developed by Pfizer (PFE.N) and BioNTech (22UAy.DE) so it can be used on 12- to 15-year-olds.
Published 5 years ago on Jun 5th 2021, 6:33 am
By Web Desk
"We have carefully reviewed clinical trial data in children aged 12 to 15 years and have concluded that the Pfizer/BioNTech COVID-19 vaccine is safe and effective in this age group and that the benefits of this vaccine outweigh any risk," June Raine, chief executive of the Medicines and Healthcare products Regulatory Agency, said.
She added that it would be up to the Joint Committee on Vaccination and Immunisation to decide whether this age group would come under the vaccine deployment programme.
Courtesy: Reuters
I asked a billionaire about his environmental philanthropy. It didn’t go well.
- 27 minutes ago
The pope takes on AI
- 28 minutes ago
Apple’s latest MacBook Air is $200 off in both sizes for Memorial Day
- 2 hours ago
Trump is waging a silent war on legal immigration
- a day ago
This mechanical bird drops dead when your home’s air quality worsens
- 2 hours ago
Why Steve Kerr Stayed With the Warriors
- a day ago
How to make the most important choice of your life
- a day ago
Philips’ new display has a screen on both sides
- 2 hours ago
Netflix’s next great sci-fi show is set in a retirement community
- 2 hours ago
Imam of Masjid-e-Nabawi urges Muslims to forge unity
- 12 hours ago
PM urges nurturing new dimensions of Pakistan-China friendship for future generations
- 12 hours ago
Nation to celebrate Eidul Azha tomorrow with religious zeal
- 12 hours ago
You May Like
